Shared Medical Appointments in Lifestyle Medicine: Evidence, Patient Privacy, and Clinical Responsibility in Viet Nam
RESEARCH & IMPLEMENTATIONEVIDENCE & CLINICAL PRACTICE
11/21/202621 min read


Shared Medical Appointments in Lifestyle Medicine: Evidence, Patient Privacy, and Clinical Responsibility in Viet Nam
Last reviewed: November 21, 2026
For many people living with chronic disease, the hardest part of following medical advice begins after they leave the clinic. A person with type 2 diabetes may understand the importance of healthier eating but struggle to change familiar family meals or maintain a consistent routine while working irregular hours. Someone with hypertension may receive appropriate treatment yet find it difficult to manage stress, improve sleep or remain physically active.
These challenges are familiar to healthcare professionals. Medical consultations are essential for assessing clinical conditions, making treatment decisions and identifying risks. Yet much of chronic disease management happens between appointments, when patients must incorporate recommendations into everyday life.
Shared Medical Appointments (SMAs) offer one way to provide additional support. They combine individualized medical care with structured group discussion, professional guidance and opportunities for patients to learn from one another. The intention is not simply to see more patients at the same time, but to bring clinical care and shared learning into a coordinated encounter.
The approach attracted renewed professional attention on October 1, 2026, when the American Journal of Lifestyle Medicine published an expert consensus statement from the American College of Lifestyle Medicine (ACLM) addressing SMAs in Lifestyle Medicine practice.[1]
For Viet Nam, the model raises questions worth exploring. Could shared appointments help healthcare organizations support patients with chronic conditions more consistently? Might they offer a practical setting for addressing the difficulties of maintaining healthy behaviors? And how can healthcare professionals protect individual clinical care and patient confidentiality when several people participate in the same encounter?
The answers depend on clinical evidence, patient preferences, organizational capacity and Vietnamese regulatory requirements. SMAs may offer benefits, but those benefits cannot be assumed simply because the model has gained international recognition.
What Makes a Shared Medical Appointment Different?
A Shared Medical Appointment, also known as a group medical visit or group consultation, brings several patients together for a planned healthcare encounter that includes both a shared component and individualized clinical care.
Participants may have similar diagnoses, risk factors or self-management needs. Healthcare professionals can address common concerns through education, discussion and behavior-change support while providing appropriate individual assessment and management.
The distinction between an SMA and a conventional health education session is important.
A hospital might organize a nutrition workshop for patients with diabetes. Participants could learn about food choices, ask questions and exchange experiences. Such an activity may be useful, but it does not automatically become an SMA because a physician attends or medical information is discussed.
An SMA includes individualized clinical care as part of the encounter. Depending on the service design, this may involve reviewing symptoms, evaluating treatment progress, assessing clinical findings, discussing medication-related concerns or making decisions about a patient's management plan.
The American Academy of Family Physicians (AAFP) recognizes shared medical appointments as voluntary encounters combining individual evaluation and management with group counseling. The individual component may take place separately or within the group process, depending on the setting and participants' needs.[4]
This flexibility matters because not every clinical issue is appropriate for group discussion. Patients may be willing to share challenges with physical activity or nutrition but prefer to discuss laboratory findings, medication changes or personal circumstances privately.
SMAs also differ from peer support groups. Although patients can benefit from hearing one another's experiences, peer support does not replace professional assessment or treatment.
The shared component is intended to complement medical care. Clinical decisions remain individual, and a patient's treatment must not be determined by the experiences or preferences of other participants.
What the 2026 ACLM Expert Consensus Establishes
The ACLM expert consensus statement published in October 2026 provides a timely professional reference for healthcare organizations interested in SMAs.[1]
A multidisciplinary panel reviewed 106 candidate statements covering eight areas: definitions and general concepts, Lifestyle Medicine and behavior change, research and quality improvement outcomes, delivery models, group cohesiveness, billing and documentation, staffing models, and training.
The panel used a structured Delphi process, in which experts evaluated statements through successive survey rounds. After three rounds, 56 statements achieved consensus, nine reached near consensus and 41 did not reach consensus.
The authors reported broad agreement among participating experts that Lifestyle Medicine SMAs have the potential to support patient satisfaction, provide high-quality care and operate within applicable reimbursement arrangements.
The consensus is particularly useful because it considers the practical requirements of group-based clinical care. It recognizes that successful implementation involves more than bringing patients together. The composition of the group, professional roles, facilitation skills, clinical documentation, staff training and organizational resources all influence how the encounter functions.
Nevertheless, an expert consensus statement is not equivalent to evidence from a randomized clinical trial.
The Delphi process identifies areas of professional agreement. It does not establish that every proposed practice is effective, that all patient groups benefit equally or that one particular SMA model is superior to conventional care.
The 41 statements that did not achieve consensus also demonstrate that important questions remain unresolved. Different healthcare settings may require different approaches to staffing, patient selection, financing and service delivery.
The discussion of reimbursement is especially important when interpreting the statement outside the United States. A service that can be reimbursed through applicable American arrangements does not automatically qualify for payment through Vietnamese health insurance or other financing mechanisms.
For Vietnamese healthcare organizations, the ACLM publication is best understood as international professional guidance that can inform local evaluation and service development. It is not a Vietnamese clinical guideline, an approved treatment protocol or authorization to introduce a new regulated healthcare service.
What Does the Clinical Evidence Show?
Research involving people with diabetes provides some of the most relevant evidence on the potential clinical benefits of SMAs.
A systematic review and meta-analysis published in BMC Primary Care in June 2025 evaluated shared medical appointments for people living with diabetes using the RE-AIM framework.[2]
The review included 47 studies, comprising 25 randomized controlled trials, 20 quasi-experimental studies and two qualitative studies. Most were conducted in the United States, with additional studies from China, Italy, Israel and Mexico.
Across 21 randomized trials reporting glycated hemoglobin outcomes, SMA interventions were associated with an average HbA1c reduction of approximately 0.38 percentage points compared with conventional care. The reported 95% confidence interval ranged from −0.55 to −0.21 percentage points.
The analysis also found that systolic blood pressure was approximately 3.24 mmHg lower in the SMA groups than in control groups across 13 randomized trials, with a 95% confidence interval from −4.71 to −1.77 mmHg.
These findings suggest that SMAs can improve selected clinical outcomes in diabetes management. However, the average effects should not be interpreted as guaranteed benefits for every patient or healthcare organization.
The interventions varied considerably. Some included medication review and treatment adjustment, while others emphasized education, behavioral counseling, peer interaction or more frequent follow-up.
When several components are delivered together, it can be difficult to determine what produced the observed improvement. A program may be more effective than usual care partly because patients receive additional professional attention or more structured support, rather than because the encounter takes place in a group.
This distinction matters when considering implementation. A clinic cannot assume that gathering patients with similar conditions will reproduce the benefits observed in research conducted with different staffing, resources or intervention intensity.
The 2025 review also identified limitations in the available implementation evidence. Clinical effectiveness was generally reported more thoroughly than the factors influencing adoption, consistent delivery, long-term maintenance and equitable access.
The authors described SMAs as complex interventions that may require substantial resources, potentially limiting their feasibility and scalability in resource-constrained settings.
Evidence from another clinical population illustrates the importance of distinguishing statistical significance from clinical importance.
A randomized clinical trial published in JAMA Internal Medicine in 2026 evaluated an eight-week, telehealth-delivered mindfulness-based group medical visit program for adults with chronic low back pain.[3]
The trial included 451 participants. At the primary six-month assessment, the intervention group experienced statistically significant improvements in pain intensity and interference compared with usual care.
The mean between-group difference on the Pain, Enjoyment of Life and General Activity scale was approximately −0.62 points.
However, this difference did not reach the study's prespecified mean minimal clinically important difference of one point between groups. The threshold was also not reached at the other evaluated time points.
This finding does not mean that the intervention provided no benefit or that individual participants could not experience meaningful improvement. It demonstrates why the magnitude of an effect, its clinical relevance and the patient's experience need to be considered alongside statistical significance.
Taken together, the evidence supports further evaluation of SMAs for selected patient populations, particularly those requiring ongoing chronic disease management and self-management support.
It does not establish that SMAs are consistently superior to individual consultations, that all group-based programs will improve clinical outcomes or that the approach will necessarily reduce healthcare expenditure.
For Viet Nam, the research provides a scientific starting point. Whether similar benefits can be achieved locally remains a question for careful evaluation.
Why SMAs May Be Relevant to Lifestyle Medicine
Lifestyle Medicine involves helping patients make and sustain changes in nutrition, physical activity, restorative sleep, stress management, avoidance of risky substances and supportive social relationships.
Providing accurate information about these areas is important, but information alone may not be enough to achieve lasting behavior change.
A patient may agree with dietary recommendations but find them difficult to reconcile with family preferences or food costs. Someone working rotating shifts may struggle to maintain regular sleep and activity patterns. Another person may understand the benefits of exercise but remain uncertain about how to begin safely while living with pain or reduced mobility.
These barriers are not simply matters of knowledge or motivation. They often reflect working conditions, family responsibilities, economic circumstances and environments that individuals have limited ability to change.
A conventional consultation can address these concerns, particularly when adequate time and professional support are available. Group encounters may offer an additional opportunity for patients to explore practical solutions with others facing comparable difficulties.
For example, one participant might describe how they adapted healthier meals to familiar Vietnamese foods without preparing separate dishes for the family. Another might explain how they incorporated physical activity into a demanding work schedule.
These experiences may help make clinical recommendations feel more realistic. Participants may also recognize that difficulties with behavior change are common and that meaningful progress does not always involve dramatic changes.
With appropriate facilitation, group discussions can encourage reflection, problem-solving and realistic goal-setting.
Such approaches align with the Lifestyle Medicine Core Competencies: 2025 Update, which recognizes behavior-change counseling, therapeutic relationships, interdisciplinary collaboration and the use of group visits and telehealth in clinical practice.[5]
The updated competencies also emphasize social determinants of health, reinforcing the importance of understanding the economic, cultural and environmental circumstances that influence patients' ability to follow clinical recommendations.
However, the presence of a supportive group does not automatically create a therapeutic benefit.
Patients may respond differently to collective discussion. Some find encouragement in hearing others' progress, while others may feel uncomfortable, compare themselves unfavorably with other participants or prefer not to disclose personal difficulties.
There is also a risk that personal experiences may be mistaken for clinical recommendations. A dietary approach or exercise routine that works for one participant may be inappropriate for someone with different medications, complications or medical needs.
The healthcare professional's role includes helping patients distinguish practical experiences from evidence-based advice and ensuring that individualized recommendations remain clinically appropriate.
Meaningful participation should be voluntary. Patients need to feel comfortable choosing what to share, when to speak and when to request private care.
Selecting Patients and Designing a Safe Group Encounter
Patient selection is one of the first decisions in SMA design.
For an initial program, a healthcare organization might consider adults attending routine follow-up for a relatively stable chronic condition, such as type 2 diabetes or hypertension, where participants have overlapping educational and self-management needs.
Even within such a group, individual clinical requirements can differ substantially.
Two patients with diabetes may have different treatment regimens, nutritional needs, levels of glycemic control and risks of complications. A person using insulin or a sulfonylurea may face hypoglycemia risks during dietary or physical activity changes that differ from those of someone receiving other treatment.
These differences need to be considered before and during the encounter.
An SMA should not delay assessment of acute symptoms, unstable disease or important treatment-related concerns. Patients requiring urgent evaluation should receive timely clinical attention through the appropriate care pathway.
Clinical complexity does not necessarily prevent participation. Some patients with multiple chronic conditions may benefit from group support alongside individual specialist care. The relevant consideration is whether their needs can be managed safely within the proposed arrangement, with access to additional assessment whenever necessary.
The group also needs to be acceptable to its participants.
Some people may be reluctant to discuss weight, medication adherence, substance use, mental health concerns or family circumstances in front of others. Hearing impairment, language differences, mobility limitations and varying levels of health literacy can also affect participation.
In Viet Nam, work schedules, transportation, financial circumstances and travel distance may influence whether repeated attendance is practical.
A program designed around weekday appointments at a large urban hospital may be difficult for shift workers or patients living far from the facility. Educational materials that are useful to highly health-literate participants may not meet the needs of everyone in the group.
These considerations should inform the service design from the beginning.
There is no universally appropriate group size, visit duration or meeting frequency. International examples can help with planning, but the final arrangement should reflect the clinical purpose, participant characteristics, available personnel, privacy requirements and time needed for individualized care.
A smaller initial program may be easier to manage while the healthcare team develops experience with group facilitation and individual clinical assessment.
What Could an SMA Look Like in a Vietnamese Clinic?
Consider an outpatient clinic seeking to strengthen long-term support for adults with type 2 diabetes.
The clinical team observes that some patients require repeated discussions about nutrition, physical activity and difficulties following agreed management plans. Rather than replacing conventional appointments, the clinic considers a small pilot combining structured group discussion with individual clinical review.
Before participation, the healthcare team assesses each patient's clinical suitability and willingness to join. Patients receive a clear explanation of the appointment, the individual and shared components, how personal information may be handled and what alternatives are available.
During the session, a trained facilitator introduces a common topic, such as managing meals during irregular working hours.
Participants may discuss their experiences and practical challenges, while the clinician helps distinguish evidence-based recommendations from personal anecdotes.
The individual clinical component remains essential.
For example, one participant may report dizziness after changing meal patterns. This should prompt appropriate individual assessment, including consideration of hypoglycemia, hypotension or other clinically relevant causes.
It would be inappropriate for other participants to speculate about medication changes or for the patient to receive generalized advice to stop treatment.
Another participant may report difficulty increasing physical activity because of pain or reduced functional capacity. That concern may require an individualized assessment, a modified activity recommendation or referral to an appropriately qualified professional.
Sensitive information and treatment decisions should be addressed privately when necessary. If a concern cannot be adequately evaluated within the planned appointment, appropriate additional care should be arranged.
Toward the end of the encounter, participants may identify achievable personal goals based on their clinical needs and circumstances.
One person might focus on improving meal planning, while another might work toward a gradual and medically appropriate increase in activity.
These goals should be individualized rather than imposed uniformly across the group.
The healthcare team would document relevant clinical findings, management decisions and follow-up arrangements in each patient's medical record.
This is an illustrative service model, not a validated Vietnamese SMA protocol. Its feasibility would depend on the facility's legally permitted activities, the qualifications and authorized scope of participating professionals, available resources and appropriate organizational arrangements.
The purpose of such a pilot would be to determine whether combining individualized care with structured group support offers meaningful benefits compared with existing services.
Protecting Patient Privacy in a Group-Based Clinical Encounter
Confidentiality is one of the most distinctive challenges of shared medical appointments.
In an individual consultation, patients generally expect their personal information to remain within the professional healthcare relationship, subject to applicable legal exceptions and authorized disclosures.
In an SMA, other participants may hear medical information, observe clinical interactions or recognize someone attending the session.
Even the fact that a person participates in a group focused on a particular condition may reveal information they would prefer to keep private.
Patients should understand these risks before deciding whether to participate.
Agreement to attend a group appointment should not be interpreted as unrestricted authorization to share medical records, laboratory findings, medication details or personal circumstances with other participants.
A person may be comfortable discussing difficulties with healthier eating while preferring that information about complications or treatment remains confidential.
Healthcare professionals should respect these preferences while ensuring that the patient still receives appropriate clinical care.
A group confidentiality agreement can help establish expectations about respecting information shared during the encounter. However, it cannot guarantee that participants will maintain confidentiality after leaving the session.
This limitation needs to be explained clearly rather than minimized.
Healthcare teams should avoid displaying identifiable medical records or investigation results to the group without an appropriate legal basis and any necessary patient authorization.
The attendance of family members, students, observers or other visitors also requires consideration. Their presence should not be assumed acceptable simply because the appointment involves a group.
Photography, audio recording and video recording introduce further privacy risks. A patient's agreement to receive care does not automatically authorize the creation, retention or publication of identifiable images or recordings.
These issues are directly relevant under Vietnamese law.
Article 10 of the Law on Medical Examination and Treatment No. 15/2023/QH15 recognizes the patient's right to dignity and privacy, including confidentiality of medical records and private information provided during medical examination and treatment, subject to legally permitted disclosures.[6]
The Law on Personal Data Protection No. 91/2025/QH15 and its implementing Decree No. 356/2025/NĐ-CP, both effective January 1, 2026, establish additional obligations concerning personal-data protection.[9,10]
Decree No. 102/2025/NĐ-CP on Health Data Management, effective July 1, 2025, is also relevant to digital health data within its applicable scope.[11]
These requirements must be considered when an SMA involves collecting, processing, displaying, storing or sharing identifiable patient information.
Virtual SMAs introduce additional concerns. Participants may join from locations where conversations can be overheard or screens can be viewed by others. Online communication may also create risks relating to unauthorized access, recording and information security.
Healthcare organizations considering virtual encounters need to assess the legal requirements applicable to remote medical examination and treatment, participant identification, access control, electronic documentation and personal-data processing.
A communication platform should not be considered suitable for handling identifiable health information merely because it is widely used or convenient.
Privacy protection is therefore more than obtaining a signed consent form. It requires appropriate service design, clear communication, professional conduct and reliable information-governance arrangements.
Professional Responsibilities and Vietnamese Legal Requirements
SMAs may involve interdisciplinary teams, but collaboration does not remove the need for clear clinical accountability.
Physicians, nurses, clinical nutrition professionals, rehabilitation practitioners, clinical psychologists and other appropriately qualified personnel may contribute according to their professional roles and the needs of patients.
A facilitator can support participation, encourage reflection and help patients explore barriers to behavior change. These skills may be valuable, particularly when discussions involve sensitive experiences or differences in patient confidence.
However, facilitating a group does not independently authorize someone to diagnose disease, prescribe medication, modify treatment or perform other regulated clinical activities.
In Viet Nam, medical examination and treatment are governed by the Law on Medical Examination and Treatment No. 15/2023/QH15, as amended and reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026.[6]
Relevant implementing requirements include Decree No. 96/2023/NĐ-CP and Circular No. 32/2023/TT-BYT, as subsequently amended, including by Circular No. 25/2026/TT-BYT.[7,8]
Circular No. 25/2026/TT-BYT has a general effective date of August 15, 2026, while its Articles 2 and 3 took effect on July 1, 2026.
The reviewed Vietnamese regulatory framework does not establish Shared Medical Appointments as an independently licensed professional field or provide general authorization to deliver regulated clinical services outside the permitted activities of healthcare facilities and practitioners.
Accordingly, the legal assessment should focus on the actual services being provided rather than the international name of the model.
If an SMA involves medical examination, diagnosis, prescribing, treatment modification or other regulated clinical activities, these must remain within the healthcare facility's legally authorized services and the participating professionals' permitted scopes of practice.
An international Lifestyle Medicine qualification does not independently expand a healthcare professional's clinical authority in Viet Nam.
The responsibilities of each team member should be established before implementation.
The healthcare organization needs reliable arrangements for individual clinical assessment, treatment decisions, documentation, referral and follow-up.
For example, a patient who reports potentially serious symptoms during a group discussion should receive timely assessment through the appropriate clinical pathway. The presence of other participants should not delay necessary care.
Similarly, when an important clinical finding requires further investigation, responsibility for arranging and following up that action should be clear.
Interdisciplinary collaboration is valuable when it strengthens care coordination. It should not create uncertainty about who is accountable for an individual patient's clinical management.
Documentation, Financing and Operational Efficiency
Medical documentation is another area in which an SMA differs from general group education.
A session record may describe attendance, educational topics and the duration of the activity. It does not replace the documentation required when individualized medical examination or treatment is delivered.
Each patient's relevant clinical findings, assessments, decisions, interventions and follow-up arrangements should be recorded in the individual medical record in accordance with applicable Vietnamese requirements.
A generic statement that the patient attended a group appointment would not adequately describe the clinical care provided.
Documentation should allow another healthcare professional to understand what occurred during the encounter, which decisions were made and what further action is required.
The financial model also deserves careful consideration.
Internationally, SMAs are sometimes promoted as an efficient approach because several patients can receive care during one scheduled encounter.
However, the number of participants does not establish operational efficiency.
The resources required may include patient screening, preparation, scheduling, professional time, clinical assessment, facilitation, documentation, facilities and subsequent follow-up.
A group encounter involving multiple healthcare professionals may require more resources than expected, even when several patients participate simultaneously.
Whether the investment is justified depends on the clinical outcomes achieved, patient experience, organizational capacity and available financing.
Although some international studies have reported favorable economic findings, these cannot be assumed to establish cost-effectiveness in Vietnamese healthcare settings.
The same caution applies to reimbursement.
The existence of reimbursement arrangements for SMAs in the United States or other countries does not establish an equivalent Vietnamese health insurance payment mechanism.
Before introducing a paid clinical SMA, healthcare organizations should review their legally authorized services, applicable pricing and billing requirements, financial governance, contractual arrangements and relevant health insurance rules.
Public and private healthcare facilities may face different approval and financing requirements.
Patients should understand whether they are participating in an educational activity, receiving a clinical service or attending an encounter that combines both components. Any applicable charges should be explained appropriately.
Transparency is important for informed decision-making and maintaining trust between patients and healthcare providers.
Evaluating an SMA Pilot in Viet Nam
An SMA pilot should begin with a clearly defined clinical or service-delivery problem.
If the objective is to improve diabetes management, relevant indicators may include HbA1c, blood pressure, treatment-related risks and appropriate follow-up.
If the objective is to strengthen self-management support, patient understanding, confidence and ability to follow a realistic care plan may be equally relevant.
However, clinical outcomes alone cannot provide a complete picture.
Evaluation should consider whether participants were appropriately selected, whether individualized care was delivered as intended and whether clinically important concerns were recognized and addressed.
Patient experience deserves particular attention.
General satisfaction may be favorable even when some participants feel uncomfortable sharing information or believe that they received insufficient individual attention.
Healthcare organizations should therefore examine whether patients understood the purpose of the group, felt comfortable with the confidentiality arrangements and had meaningful opportunities to request private care.
The evaluation should also consider people who do not participate.
A program may primarily attract patients who are highly motivated, have flexible schedules or feel comfortable engaging in group discussions.
If those participants experience favorable outcomes, the results may not reflect what would happen among patients facing greater financial, geographical or social barriers.
The RE-AIM framework offers one approach to examining these questions.[2]
It considers reach, effectiveness, adoption, implementation and maintenance. These dimensions help organizations assess not only whether a program produces favorable outcomes, but also whether it reaches the intended population, can be delivered consistently and remains feasible over time.
Safety monitoring should address risks associated with the group format, including confidentiality incidents, delayed recognition of clinical concerns, incomplete documentation, inappropriate advice shared during discussions and treatment-related complications.
Financial evaluation should consider the full resources required to deliver the service rather than only the duration of the group appointment.
Where feasible, outcomes should be compared with an appropriate baseline or alternative care model.
A simple improvement observed before and after participation does not establish that the SMA caused the change. Medication adjustments, differences in disease severity, additional clinical attention and other factors may also influence outcomes.
For an initial Vietnamese pilot, a focused evaluation of safety, acceptability, feasibility, implementation fidelity, patient-relevant outcomes and resource requirements may be more informative than attempting rapid expansion.
An unsuccessful or inconclusive pilot can still provide useful information.
The findings may indicate that participants need smaller groups, more private consultation time, different staffing arrangements or a narrower clinical focus.
Some healthcare organizations may conclude that structured group education combined with conventional individual appointments is more suitable than a formal SMA.
That would be a legitimate outcome if it better serves patients and fits the organization's clinical and operational capabilities.
The purpose of evaluating an SMA is not to prove that the model must work. It is to determine whether the approach offers sufficient additional value to justify its use in a particular healthcare setting.
The Opportunity for Vietnamese Healthcare
Shared Medical Appointments may offer a practical way to strengthen ongoing support for patients living with chronic conditions, particularly where sustained behavior change is an important component of care.
International research provides encouraging findings in selected populations, and the 2026 ACLM consensus offers a professional reference for considering how SMAs can be organized.
Nevertheless, their introduction into Vietnamese healthcare requires more than adapting an international appointment format.
Healthcare organizations need to determine which patients may benefit, what individualized clinical services will be delivered, how confidentiality will be protected and how professional responsibilities will be maintained.
The model must also be realistic for patients.
Work schedules, transportation, family responsibilities, health literacy, financial circumstances and access to care can all influence whether repeated group participation is practical.
A service that works well in a large urban hospital may require a different approach in a smaller clinic or a setting serving patients with different needs.
The most appropriate starting point is a clearly identified clinical need that existing services are not adequately addressing.
Healthcare organizations can then assess whether an SMA provides a plausible improvement, taking account of patient preferences, clinical resources and applicable regulatory requirements.
Patients should participate in evaluating the proposed arrangement. Their experiences may reveal concerns about privacy, accessibility, communication and group interaction that are not immediately apparent to professionals designing the service.
Implementation should proceed at a scale that allows close observation and adjustment.
A well-designed SMA may help patients learn from others, explore practical barriers and maintain greater engagement with their care. However, these advantages should never come at the expense of individualized assessment, confidential treatment or clear professional accountability.
Better Care, Not Simply More Appointments
The growing international interest in Shared Medical Appointments reflects a broader recognition that chronic disease management often requires continuing relationships, practical support and opportunities for patients to remain engaged in their care.
The group setting may help make medical recommendations more understandable and easier to incorporate into daily life. It may also provide encouragement that is difficult to achieve through brief, isolated consultations.
These possibilities deserve careful evaluation in Viet Nam, where chronic disease management must respond to diverse clinical needs and social circumstances.
The goal is not to replace individual care with group activities or to increase the number of patients seen at the expense of clinical quality.
A well-designed SMA should allow people to learn together while retaining appropriate individual assessment, access to confidential care and clear professional responsibility.
Its value should be demonstrated through patient-relevant outcomes, clinical safety, acceptability and sustainable service delivery.
Ultimately, the question is not how many patients can be brought into one consultation room. It is whether the shared encounter helps each person receive care that is safe, appropriate and more useful than the care they would otherwise have received.
That is the standard by which Shared Medical Appointments should be evaluated in Vietnamese healthcare.
References and Further Reading
Gardiner P, Frates B, Rosenfeld RM, et al. Shared Medical Appointments (SMAs) in Lifestyle Medicine Practice: An Expert Consensus Statement From the American College of Lifestyle Medicine. American Journal of Lifestyle Medicine. Published online October 1, 2026. doi:10.1177/15598276261485880.
Yang W, Mao R, Liang Z, et al. Using the RE-AIM Framework to Evaluate the Impact of Shared Medical Appointments for Diabetes Mellitus: A Systematic Review and Meta-Analysis. BMC Primary Care. 2025;26:192. doi:10.1186/s12875-025-02875-1.
Morone NE, Faurot KR, Weinberg J, et al. Mindfulness-Based Group Medical Visits for Persons With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Internal Medicine. 2026;186(9):1090–1099. doi:10.1001/jamainternmed.2026.2186.
American Academy of Family Physicians. Shared Medical Appointments/Group Visits. Professional policy statement. Revised September 2024.
Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. doi:10.1177/15598276251379821.
National Assembly of Viet Nam. Law on Medical Examination and Treatment No. 15/2023/QH15, January 9, 2023, as amended. Office of the National Assembly, Consolidated Document No. 26/VBHN-VPQH, February 26, 2026.
Government of Viet Nam. Decree No. 96/2023/NĐ-CP, December 30, 2023, Detailing Selected Provisions of the Law on Medical Examination and Treatment, as applicable.
Ministry of Health of Viet Nam. Circular No. 32/2023/TT-BYT, December 31, 2023, Detailing Selected Provisions of the Law on Medical Examination and Treatment, as subsequently amended, including by Circular No. 25/2026/TT-BYT, June 30, 2026. General effective date: August 15, 2026; Articles 2 and 3 effective July 1, 2026.
National Assembly of Viet Nam. Law on Personal Data Protection No. 91/2025/QH15, June 26, 2025. Effective January 1, 2026.
Government of Viet Nam. Decree No. 356/2025/NĐ-CP, December 31, 2025, Detailing Selected Provisions and Implementation Measures of the Law on Personal Data Protection. Effective January 1, 2026.
Government of Viet Nam. Decree No. 102/2025/NĐ-CP, May 13, 2025, on Health Data Management. Effective July 1, 2025.
Professional, Clinical and Regulatory Note
This article is published by the Vietnam Lifestyle Medicine Alliance (VLMA) for professional education, scientific knowledge exchange and discussion of evidence-based Lifestyle Medicine in Viet Nam.
It reviews international research and professional guidance concerning Shared Medical Appointments and discusses considerations relevant to their potential implementation within Vietnamese healthcare.
The article is intended for educational and professional discussion. It does not constitute a Vietnamese national clinical guideline, an approved medical treatment protocol, an accreditation standard, a service-pricing determination or an authoritative legal opinion.
The illustrative service models, patient selection considerations, staffing arrangements and evaluation approaches discussed are not presented as nationally validated Vietnamese clinical protocols or mandatory professional requirements.
Any implementation involving regulated healthcare activities must comply with applicable Vietnamese legislation, the healthcare facility's legally authorized services, the qualifications and permitted professional scope of participating practitioners, patient rights, medical documentation requirements, personal-data protection obligations and relevant organizational approval processes.
Participation in an SMA must not delay clinically indicated medical examination, diagnostic evaluation, medication management, treatment, referral or emergency care.
International expert consensus and research findings do not establish automatic regulatory authorization, health insurance reimbursement, cost-effectiveness or clinical benefit in Viet Nam.
VLMA supports evidence-based professional education, scientific knowledge exchange and responsible implementation. It does not independently authorize healthcare facilities to deliver regulated clinical services, grant professional practice licenses, certify SMA programs or approve particular clinical implementation models.
The scientific and regulatory sources referenced in this article were reviewed through November 21, 2026. Healthcare organizations considering implementation should verify the current legal requirements applicable to their specific services and circumstances before introducing any clinical program or making patient-facing claims.
Vietnam Lifestyle Medicine Alliance
Evidence-Based Lifestyle Medicine for Viet Nam.
Contact
contact@vlma.org
Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC
+84 909 228 476
+84 84 9999 911
© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.
A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.
VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.
VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.
VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.
